Sonia M Amaral

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors

Brian J.P. Huntly, Hirokazu Shigematsu, Kenji Deguchi et al. · Cancer Cell · 2004 · 699 citations · Full text

Life Sciences, Cell Biology, Hematology +16

PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model

Louise Kelly, Jeffrey L. Kutok, Ifor R. Williams et al. · Proceedings of the National Academy of Sciences · 2002 · 332 citations · Full text

Medicine, Genetics, Molecular Biology +15

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

Medicine, Oncology, Pharmacology +10

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease

Jan Cools, Elizabeth H. Stover, Christina Boulton et al. · Cancer Cell · 2003 · 218 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model

Benjamin H. Lee, Ifor R. Williams, Ema Anastasiadou et al. · Oncogene · 2005 · 78 citations

Life Sciences, Genetics, Molecular Genetics +13